UniProt ID | CBX4_HUMAN | |
---|---|---|
UniProt AC | O00257 | |
Protein Name | E3 SUMO-protein ligase CBX4 | |
Gene Name | CBX4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 560 | |
Subcellular Localization | Nucleus . Nucleus speckle . Localization to nuclear polycomb bodies is required for ZNF131 sumoylation (PubMed:22467880). Localized in distinct foci on chromatin (PubMed:18927235). | |
Protein Description | E3 SUMO-protein ligase which facilitates SUMO1 conjugation by UBE2I. [PubMed: 12679040 Involved in the sumoylation of HNRNPK, a p53/TP53 transcriptional coactivator, hence indirectly regulates p53/TP53 transcriptional activation resulting in p21/CDKN1A expression. Monosumoylates ZNF131] | |
Protein Sequence | MELPAVGEHVFAVESIEKKRIRKGRVEYLVKWRGWSPKYNTWEPEENILDPRLLIAFQNRERQEQLMGYRKRGPKPKPLVVQVPTFARRSNVLTGLQDSSTDNRAKLDLGAQGKGQGHQYELNSKKHHQYQPHSKERAGKPPPPGKSGKYYYQLNSKKHHPYQPDPKMYDLQYQGGHKEAPSPTCPDLGAKSHPPDKWAQGAGAKGYLGAVKPLAGAAGAPGKGSEKGPPNGMMPAPKEAVTGNGIGGKMKIVKNKNKNGRIVIVMSKYMENGMQAVKIKSGEVAEGEARSPSHKKRAADERHPPADRTFKKAAGAEEKKVEAPPKRREEEVSGVSDPQPQDAGSRKLSPTKEAFGEQPLQLTTKPDLLAWDPARNTHPPSHHPHPHPHHHHHHHHHHHHAVGLNLSHVRKRCLSETHGEREPCKKRLTARSISTPTCLGGSPAAERPADLPPAAALPQPEVILLDSDLDEPIDLRCVKTRSEAGEPPSSLQVKPETPASAAVAVAAAAAPTTTAEKPPAEAQDEPAESLSEFKPFFGNIIITDVTANCLTVTFKEYVTV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
28 | Phosphorylation | IRKGRVEYLVKWRGW CCCCCCEEEEEECCC | 17.59 | - | |
36 | Phosphorylation | LVKWRGWSPKYNTWE EEEECCCCCCCCCCC | 17.84 | 24719451 | |
38 | Ubiquitination | KWRGWSPKYNTWEPE EECCCCCCCCCCCCH | 45.69 | - | |
77 | Sumoylation | RKRGPKPKPLVVQVP HHCCCCCCCEEEECC | 58.05 | 28112733 | |
90 | Phosphorylation | VPTFARRSNVLTGLQ CCCCCHHCCCCCCCC | 26.24 | 28985074 | |
94 | Phosphorylation | ARRSNVLTGLQDSST CHHCCCCCCCCCCCC | 31.40 | 29978859 | |
99 | Phosphorylation | VLTGLQDSSTDNRAK CCCCCCCCCCCCCEE | 23.37 | 29978859 | |
100 | Phosphorylation | LTGLQDSSTDNRAKL CCCCCCCCCCCCEEE | 48.33 | 29978859 | |
101 | Phosphorylation | TGLQDSSTDNRAKLD CCCCCCCCCCCEEEE | 41.04 | 29978859 | |
106 | Sumoylation | SSTDNRAKLDLGAQG CCCCCCEEEECCCCC | 39.02 | 28112733 | |
106 | Acetylation | SSTDNRAKLDLGAQG CCCCCCEEEECCCCC | 39.02 | 25953088 | |
106 | Ubiquitination | SSTDNRAKLDLGAQG CCCCCCEEEECCCCC | 39.02 | - | |
106 | Sumoylation | SSTDNRAKLDLGAQG CCCCCCEEEECCCCC | 39.02 | - | |
114 | Sumoylation | LDLGAQGKGQGHQYE EECCCCCCCCCCEEE | 35.66 | 28112733 | |
114 | Sumoylation | LDLGAQGKGQGHQYE EECCCCCCCCCCEEE | 35.66 | - | |
114 | Ubiquitination | LDLGAQGKGQGHQYE EECCCCCCCCCCEEE | 35.66 | - | |
120 | Phosphorylation | GKGQGHQYELNSKKH CCCCCCEEECCCCCC | 19.40 | 27642862 | |
125 | Ubiquitination | HQYELNSKKHHQYQP CEEECCCCCCCCCCC | 55.86 | - | |
125 | Acetylation | HQYELNSKKHHQYQP CEEECCCCCCCCCCC | 55.86 | 25953088 | |
125 | Sumoylation | HQYELNSKKHHQYQP CEEECCCCCCCCCCC | 55.86 | 28112733 | |
137 | Methylation | YQPHSKERAGKPPPP CCCCCCCCCCCCCCC | 52.99 | - | |
147 | Phosphorylation | KPPPPGKSGKYYYQL CCCCCCCCCCEEEEE | 46.57 | 25072903 | |
149 | Ubiquitination | PPPGKSGKYYYQLNS CCCCCCCCEEEEECC | 36.85 | 19608861 | |
149 | Acetylation | PPPGKSGKYYYQLNS CCCCCCCCEEEEECC | 36.85 | 19608861 | |
149 | Sumoylation | PPPGKSGKYYYQLNS CCCCCCCCEEEEECC | 36.85 | - | |
149 | Sumoylation | PPPGKSGKYYYQLNS CCCCCCCCEEEEECC | 36.85 | 28112733 | |
150 | Phosphorylation | PPGKSGKYYYQLNSK CCCCCCCEEEEECCC | 15.78 | 25072903 | |
151 | Phosphorylation | PGKSGKYYYQLNSKK CCCCCCEEEEECCCC | 6.55 | 25072903 | |
152 | Phosphorylation | GKSGKYYYQLNSKKH CCCCCEEEEECCCCC | 11.93 | 25072903 | |
157 | Acetylation | YYYQLNSKKHHPYQP EEEEECCCCCCCCCC | 55.86 | 25953088 | |
157 | Sumoylation | YYYQLNSKKHHPYQP EEEEECCCCCCCCCC | 55.86 | 28112733 | |
158 | Ubiquitination | YYQLNSKKHHPYQPD EEEECCCCCCCCCCC | 47.14 | - | |
167 | Sumoylation | HPYQPDPKMYDLQYQ CCCCCCCCCCCCCCC | 58.43 | 28112733 | |
167 | Ubiquitination | HPYQPDPKMYDLQYQ CCCCCCCCCCCCCCC | 58.43 | - | |
169 | Phosphorylation | YQPDPKMYDLQYQGG CCCCCCCCCCCCCCC | 21.45 | 26552605 | |
173 | Phosphorylation | PKMYDLQYQGGHKEA CCCCCCCCCCCCCCC | 19.20 | 29214152 | |
178 | Ubiquitination | LQYQGGHKEAPSPTC CCCCCCCCCCCCCCC | 59.87 | - | |
178 | Sumoylation | LQYQGGHKEAPSPTC CCCCCCCCCCCCCCC | 59.87 | 28112733 | |
182 | Phosphorylation | GGHKEAPSPTCPDLG CCCCCCCCCCCCCCC | 39.63 | 30266825 | |
184 | Phosphorylation | HKEAPSPTCPDLGAK CCCCCCCCCCCCCCC | 40.79 | 30266825 | |
191 | Sumoylation | TCPDLGAKSHPPDKW CCCCCCCCCCCCCHH | 47.72 | 28112733 | |
197 | Acetylation | AKSHPPDKWAQGAGA CCCCCCCHHHCCCCC | 50.64 | 25953088 | |
197 | Ubiquitination | AKSHPPDKWAQGAGA CCCCCCCHHHCCCCC | 50.64 | - | |
205 | Sumoylation | WAQGAGAKGYLGAVK HHCCCCCCCCHHCHH | 47.36 | - | |
205 | Ubiquitination | WAQGAGAKGYLGAVK HHCCCCCCCCHHCHH | 47.36 | - | |
205 | Sumoylation | WAQGAGAKGYLGAVK HHCCCCCCCCHHCHH | 47.36 | 28112733 | |
207 | Phosphorylation | QGAGAKGYLGAVKPL CCCCCCCCHHCHHCC | 10.97 | 18083107 | |
212 | Ubiquitination | KGYLGAVKPLAGAAG CCCHHCHHCCCCCCC | 33.51 | - | |
212 | Acetylation | KGYLGAVKPLAGAAG CCCHHCHHCCCCCCC | 33.51 | 25953088 | |
212 | Sumoylation | KGYLGAVKPLAGAAG CCCHHCHHCCCCCCC | 33.51 | - | |
212 | Sumoylation | KGYLGAVKPLAGAAG CCCHHCHHCCCCCCC | 33.51 | 28112733 | |
223 | Sumoylation | GAAGAPGKGSEKGPP CCCCCCCCCCCCCCC | 59.20 | 28112733 | |
223 | Sumoylation | GAAGAPGKGSEKGPP CCCCCCCCCCCCCCC | 59.20 | - | |
223 | Ubiquitination | GAAGAPGKGSEKGPP CCCCCCCCCCCCCCC | 59.20 | - | |
249 | Sumoylation | TGNGIGGKMKIVKNK CCCCCCCCEEEEECC | 31.63 | 28112733 | |
249 | Sumoylation | TGNGIGGKMKIVKNK CCCCCCCCEEEEECC | 31.63 | - | |
249 | Ubiquitination | TGNGIGGKMKIVKNK CCCCCCCCEEEEECC | 31.63 | - | |
249 | Methylation | TGNGIGGKMKIVKNK CCCCCCCCEEEEECC | 31.63 | - | |
249 | Acetylation | TGNGIGGKMKIVKNK CCCCCCCCEEEEECC | 31.63 | 25953088 | |
267 | Phosphorylation | GRIVIVMSKYMENGM CCEEEEECHHHHCCE | 15.11 | 20068231 | |
268 | Sumoylation | RIVIVMSKYMENGMQ CEEEEECHHHHCCEE | 30.44 | 28112733 | |
269 | Phosphorylation | IVIVMSKYMENGMQA EEEEECHHHHCCEEE | 11.45 | 20068231 | |
278 | Ubiquitination | ENGMQAVKIKSGEVA HCCEEEEEEECCCCC | 47.64 | - | |
278 | Sumoylation | ENGMQAVKIKSGEVA HCCEEEEEEECCCCC | 47.64 | - | |
278 | Sumoylation | ENGMQAVKIKSGEVA HCCEEEEEEECCCCC | 47.64 | 28112733 | |
280 | Ubiquitination | GMQAVKIKSGEVAEG CEEEEEEECCCCCCC | 46.84 | - | |
280 | Sumoylation | GMQAVKIKSGEVAEG CEEEEEEECCCCCCC | 46.84 | 28112733 | |
280 | Sumoylation | GMQAVKIKSGEVAEG CEEEEEEECCCCCCC | 46.84 | - | |
281 | Phosphorylation | MQAVKIKSGEVAEGE EEEEEEECCCCCCCC | 43.59 | 29396449 | |
291 | Phosphorylation | VAEGEARSPSHKKRA CCCCCCCCHHHHHHH | 37.49 | 23401153 | |
293 | Phosphorylation | EGEARSPSHKKRAAD CCCCCCHHHHHHHHH | 49.54 | 21955146 | |
320 | Sumoylation | AAGAEEKKVEAPPKR HCCCHHHCCCCCCCC | 48.89 | 28112733 | |
333 | Phosphorylation | KRREEEVSGVSDPQP CCCHHHHCCCCCCCC | 36.44 | 26074081 | |
336 | Phosphorylation | EEEVSGVSDPQPQDA HHHHCCCCCCCCCCC | 47.28 | 20044836 | |
345 | Phosphorylation | PQPQDAGSRKLSPTK CCCCCCCCCCCCCCH | 28.14 | 28985074 | |
349 | Phosphorylation | DAGSRKLSPTKEAFG CCCCCCCCCCHHHHC | 33.29 | 23927012 | |
351 | Phosphorylation | GSRKLSPTKEAFGEQ CCCCCCCCHHHHCCC | 37.83 | 23927012 | |
352 | Sumoylation | SRKLSPTKEAFGEQP CCCCCCCHHHHCCCC | 50.89 | 28112733 | |
363 | Phosphorylation | GEQPLQLTTKPDLLA CCCCCCCCCCCCCEE | 21.58 | 23927012 | |
364 | Phosphorylation | EQPLQLTTKPDLLAW CCCCCCCCCCCCEEC | 49.53 | 23927012 | |
365 | Sumoylation | QPLQLTTKPDLLAWD CCCCCCCCCCCEECC | 31.16 | 28112733 | |
365 (in isoform 1) | Ubiquitination | - | 31.16 | 21906983 | |
365 | Sumoylation | QPLQLTTKPDLLAWD CCCCCCCCCCCEECC | 31.16 | - | |
365 | Ubiquitination | QPLQLTTKPDLLAWD CCCCCCCCCCCEECC | 31.16 | 2190698 | |
415 | Phosphorylation | HVRKRCLSETHGERE HHHHHHHHHCCCCCC | 44.04 | 29255136 | |
417 | Phosphorylation | RKRCLSETHGEREPC HHHHHHHCCCCCCCC | 31.63 | 19276368 | |
429 | Phosphorylation | EPCKKRLTARSISTP CCCHHHHCCCCCCCC | 24.86 | 26074081 | |
432 | Phosphorylation | KKRLTARSISTPTCL HHHHCCCCCCCCCCC | 20.58 | 29255136 | |
434 | Phosphorylation | RLTARSISTPTCLGG HHCCCCCCCCCCCCC | 29.58 | 29255136 | |
435 | Phosphorylation | LTARSISTPTCLGGS HCCCCCCCCCCCCCC | 22.43 | 23663014 | |
437 | Phosphorylation | ARSISTPTCLGGSPA CCCCCCCCCCCCCCC | 22.05 | 29255136 | |
442 | Phosphorylation | TPTCLGGSPAAERPA CCCCCCCCCCCCCCC | 15.01 | 28387310 | |
467 | Phosphorylation | PEVILLDSDLDEPID CCEEEECCCCCCCEE | 39.79 | 27499020 | |
480 | Phosphorylation | IDLRCVKTRSEAGEP EEEEEEECCCCCCCC | 21.01 | 26074081 | |
482 | Phosphorylation | LRCVKTRSEAGEPPS EEEEECCCCCCCCCC | 36.71 | 26074081 | |
494 | Sumoylation | PPSSLQVKPETPASA CCCCCCCCCCCCHHH | 24.95 | - | |
494 | Sumoylation | PPSSLQVKPETPASA CCCCCCCCCCCCHHH | 24.95 | 15592428 | |
495 | Phosphorylation | PSSLQVKPETPASAA CCCCCCCCCCCHHHH | 52.41 | 17018294 | |
497 | Phosphorylation | SLQVKPETPASAAVA CCCCCCCCCHHHHHH | 32.45 | 28112733 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CBX4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-149, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND MASSSPECTROMETRY. | |
Sumoylation | |
Reference | PubMed |
"Multiple activities contribute to Pc2 E3 function."; Kagey M.H., Melhuish T.A., Powers S.E., Wotton D.; EMBO J. 24:108-119(2005). Cited for: SUMOYLATION AT LYS-494. |